NEW U.S. NUTRITION GUIDELINES INTRODUCE AN INVERTED PYRAMID
The U.S. Department of Health and Human Services (HHS) and […]
Read moreWEIGHT LOSS WITH GLP-1: THE CRUCIAL ROLE OF NUTRITION
An overview of how evidence-based nutrition influences the effectiveness, safety, and sustainability of GLP-1–based approaches to obesity treatment
A recent multi-journal publication—featured in The American Journal of Clinical Nutrition (AJCN), Obesity, American Journal of Lifestyle Medicine (AJLM), and Obesity Pillars—highlights essential nutritional and lifestyle strategies to enhance the effectiveness of GLP-1 receptor agonists in individuals with obesity.
While GLP-1 therapies have demonstrated weight loss reductions of 5–18% in randomized controlled trials, their effectiveness is often reduced in real-world practice. Contributing factors include limited clinician and public awareness of nutrition and lifestyle interventions, as well as the everyday challenges encountered in routine care.
These challenges include:
- Loss of muscle mass
- Nutritional deficiencies
- Early treatment discontinuation
- Weight regain
- High economic burden
The publication draws attention to the importance of integrating nutritional support in GLP-1 therapies to reduce potential risks. It presents a framework of evidence-based strategies to enhance clinical outcomes. From a nutritional standpoint, the following priorities are key to successful GLP-1 therapy:
- Initiation of GLP-1 therapy with a patient-centered approach
- Completion of baseline nutritional assessment and screening
- Managements of gastrointestinal side effects
- Navigation of dietary preferences and intakes
- Prevention and mitigation of nutrient deficiencies
- Preservation of muscle and bone mass
- Maximization of weight reduction efficacy
- Promotion of other supportive lifestyle measures
Nutrition and lifestyle support are fundamental to maximize the benefits, minimize side effects, and ensure the long-term sustainability of GLP-1–based obesity treatment.
References:
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025 May 30. See the link.
